Skip to main content

ACD Announces Preferred Partnership with MicroMatrices

NEW YORK (GenomeWeb) – Advanced Cell Diagnostics announced today a preferred partnership agreement with Dundee, UK-based MicroMatrices to develop applications of its RNAscope technology.

ACD's RNAscope assays allow for single RNA molecule detection of formalin-fixed, paraffin-embedded tissue samples, offering quantitative molecular detection with morphological context in a single assay. MicroMatrices has expertise in using RNAscope to detect RNA-based biomarkers in situ, the companies said in a statement, and will now aim to develop preclinical applications of the technology.

"The power and versatility of RNAscope has been an invaluable tool to enable us to solve mode of action/efficacy/toxicity challenges for our clients in the pharmaceutical, agrochemical, and chemical industries," Simon Plummer, managing director of MicroMatrices, said.

Financial and other terms of the deal were not provided.

MicroMatrices is a service provider specializing in high resolution cell type-specific analysis to characterize toxicological responses in different cell types and tissues.

Hayward, Calif.-based ACD develops cell and tissue-based diagnostic tests for personalized medicine.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.